Journal of Endovascular Therapy, published by SAGE Publications Inc., has established itself as a leading source of research and innovation in the fields of Cardiology, Cardiovascular Medicine, Radiology, and Surgery. With an impressive impact factor and recognized in the Q1 quartile for its contributions, this journal is essential for professionals and researchers dedicated to advancing the practice of endovascular therapy. The journal, which has been in circulation since 2000, covers a wide range of topics pertinent to endovascular procedures and therapeutics, offering valuable insights and findings that drive clinical practice and enhance patient outcomes. With its emphasis on high-quality peer-reviewed content, the Journal of Endovascular Therapy serves as a vital resource for both established experts and emerging scholars in the medical community. Access to the journal is facilitated for a wider audience, ensuring that innovative research reaches practitioners and academics worldwide, fostering an environment of collaboration and knowledge exchange.

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

CLINICAL NEUROLOGY AND NEUROSURGERY, published by Elsevier, is a pivotal journal in the fields of neurology and neurosurgery, recognized for its rigorous peer-review process and commitment to advancing clinical practices. Established in 1974, the journal has become a respected source of innovative research, evidenced by its excellent Scopus rankings—placing it within the top half of journals in both Medicine (Surgery) and the clinical aspect of Neurology. Notably, it has achieved a Q2 ranking in both Medicine (miscellaneous) and Surgery, and Q3 in Neurology (clinical) as of 2023. The journal publishes a wide array of articles focused on the latest findings, clinical practices, and technological advancements that address neurological disorders and surgical interventions. While it does not currently operate under an open-access model, it remains highly accessible to academic institutions and professionals worldwide from its editorial base in the Netherlands. By enabling knowledge-sharing and fostering collaboration among researchers, practitioners, and students, CLINICAL NEUROLOGY AND NEUROSURGERY plays a crucial role in shaping the future of clinical neurology and surgical techniques.

Angiologia, published by ARAN EDICIONES, S A, serves as a vital platform for the dissemination of research and advancements in the fields of cardiology and cardiovascular medicine. Established in 1949, this Spanish journal has made significant contributions to understanding vascular health, although it currently holds a Q4 status in Scopus rankings, indicating a critical opportunity for emerging researchers to contribute to this evolving field. Spanning from 1949 to 1993 and resuming from 1996 to 2024, the journal reflects a rich history of academic discourse. With its ISSN 0003-3170 and E-ISSN 1695-2987, Angiologia is committed to enhancing the visibility of cardiovascular research, providing access to a diverse range of articles that cater to the needs of healthcare professionals, academics, and students aiming to deepen their understanding of angiological health. While the journal currently does not offer open access options, it remains significant in guiding future research and fostering innovations within the cardiology landscape.

ANNALS OF VASCULAR SURGERY is a premier journal published by Elsevier Science Inc, focusing on the rapidly evolving field of vascular surgery and its related disciplines. With a notable impact factor reflected in its 2023 Q2 rankings in Cardiology and Cardiovascular Medicine, as well as in Medicine and Surgery, this journal stands out as a reputable source for cutting-edge research and clinical practices. Since its inception in 1986, it has aimed to advance knowledge, foster innovation, and enhance surgical techniques through comprehensive reviews, original research articles, and clinical trials. Although not currently adopting an open access model, the journal continues to serve as a crucial repository of information for researchers, clinicians, and students, facilitating the dissemination of clinical and scientific advancements in vascular health. As it converges through the years towards 2024, the ANNALS OF VASCULAR SURGERY is poised to remain a valuable resource for the global medical community.

Circulation-Cardiovascular Interventions, published by LIPPINCOTT WILLIAMS & WILKINS, is a premier journal in the field of cardiology and cardiovascular medicine, recognized for its commitment to advancing the understanding and treatment of cardiovascular diseases. With a robust Impact Factor and ranking in the top 10% of its category, it serves as an essential resource for researchers, clinicians, and students seeking to stay at the forefront of cardiovascular intervention developments. This esteemed journal covers a range of topics, including innovative therapeutic strategies, cutting-edge clinical trials, and comprehensive reviews that inform clinical practice and influence guidelines. Since its inception in 2008, and extending through 2024, Circulation-Cardiovascular Interventions has published pivotal research that shapes the landscape of cardiovascular care in the United States and beyond. Its commitment to high-quality publications makes it an invaluable platform for sharing knowledge and fostering collaboration within the global medical community.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

JOURNAL OF THE NEUROLOGICAL SCIENCES, published by Elsevier, is a leading academic journal that has been at the forefront of neurology research since its inception in 1964. With a robust scope covering both clinical and experimental neurological sciences, this journal serves as an invaluable resource for researchers, practitioners, and students in the field. The journal is indexed with an impressive Q2 ranking in Neurology and a remarkable Q1 status in Clinical Neurology as of 2023, reflecting its high impact and relevance in the medical community. The journal's Scopus rankings further emphasize its significance, holding the 69th position in clinical neurology and 35th in neuroscience, marking it in the top 82nd percentile of its peers. While the journal operates under a traditional subscription model, it continues to offer a platform for groundbreaking research and comprehensive reviews that advance our understanding of neurological disorders. Researchers and clinicians alike will find the JOURNAL OF THE NEUROLOGICAL SCIENCES an essential contribution to the literature, paving the way for innovations in clinical practices and therapeutic strategies.